During early human pregnancy, extravillous trophoblast cells invade the maternal tissue of the uterus in a way similar to invasion by cancer cells. However, the process of trophoblast invasion is regulated in a time and place restricted way, in contrast to cancer invasion. We screened first trimester placental tissue enriched by extravillous invasive trophoblasts for the expression of proneural basic helix-loop-helix (bHLH) transcription factors, which are important controllers of cell fate. Surprisingly, the presence of NEUROD1, NEUROD2 and ATH2 transcripts was found by reverse transcriptase polymerase chain reaction (RT-PCR) analysis in first trimester placentabed. Of these genes, the proneural genes NEUROD1 and NEUROD2 are expressed in different subsets of invasive trophoblasts. NEUROD1 expression is found in interstitial and endovascular invasive cells, while NEUROD2 expression is observed mainly in endovascular invasive cells, respectively. These data suggest that in addition to the involvement of proneural genes in neuron, neurendocrine and pancreas differentiation, these genes are involved in trophoblast differentation during progression of invasion. q
Results and discussion
During human placentation, villi are formed from week 4-20. On the top of the villi, proliferative cytotrophoblast precursors are located. The precursors cells subsequently downregulate proliferation, leave the villous tip and adopt an invasive phenotype, characteristic of extravillous trophoblasts (Fig. 1) . From the distal column and onward, the human extravillous trophoblasts specifically express the class I MHC molecule HLA-G (Kovats et al., 1990) . The extravillous trophoblasts invade into the maternal decidua and inner third of the myometrium and reach the maternal spiral arteries. As a consequence, the arterial wall is modified and the endothelium of the spiral arteries is replaced by these invasive cytotrophoblasts, a process called endovascularization (Zhou et al., 1997) .
In rodent placentas, two basic helix-loop-helix (bHLH) transcription factors have been identified as key regulators of differentiation of trophoblasts, Mash2 and Hand1. The mammalian achaete-scute homolog 2 transcription factor, Mash2 (Johnson et al., 1990; Guillemot et al., 1994) is essential for normal development of the spongiotrophoblast lineage of the placenta (Guillemot et al., 1994; Cross et al., 1995; Tananaka et al., 1997) , while Hand1 promotes terminal differentiation into giant cells (Cross et al., 1995 , Firulli et al., 1998 Riley et al., 1998) . Indeed, previously performed cDNA library analysis of human first trimester placenta tissue in our laboratory showed the presence of the human homologs ASCL2 (HASH2/HASAP), maternally expressed HAND2 and hardly detectable HAND1 expression (data not shown).
RNA of placentabed tissue (10773, week 13), containing decidua-myometrium zone I-V (Fig. 1) was screened comprehensively for bHLH transcription factor expression by reverse transcriptase polymerase chain reaction (RT-PCR). All known members of the bHLH sub-families Achaete-Scute, NeuroD, Neurogenin, Atonal and Beta were included in this screening. Members were classified in sub-families according to amino acid homology in the bHLH domain (Table 1) . Expression profiles were made of brain, villous fibroblasts and placentabed, respectively (Fig. 2) . All analyzed genes were expressed in fetal brain (week 13), as expected. In the villous fibroblasts, only ASCL2 (HASH2/HASAP) expression was observed, which is in agreement with our previous data (Westerman et al., 2001) . Surprisingly, expression of the proneural genes NEUROD1, NEUROD2 and ATH2 was reproducibly detected in the placentabed. These results were confirmed by additional analysis of comparable placentabed tissue of different women (data not shown).
Localization of protein expression of the proneural genes was performed by triple immunohistochemistry followed by analysis with confocal laser scan microscopy. Proliferative cells were stained using MIB-1 monoclonal antibody, which recognizes the proliferation marker Ki-67. Extravillous cytotrophoblasts positive for HLA-G were stained with the G233 monoclonal antibody (Loke et al., 1997) . Endothelial cells were stained by an anti-CD31 monoclonal antibody.
Immunostaining for NEUROD1 in combination with HLA-G and Ki-67 or CD31 is shown in Fig. 3A -D. These results show (Fig. 3A) proliferative Ki-67 positive cytotrophoblasts (blue) in zone II and III of the tissue and show HLA-G positive cells (red), representing cytotrophoblasts of the distal column. In the interstitial zone IV (Fig.  3B ), HLA-G positive cells were observed. In a subset of these HLA-G positive cells, expression of NEUROD1 was observed (green, indicated by arrows). Co-localization is visualized by the yellow color (red/green). Deeper in the tissue ( Fig. 3C ), increased numbers of NEUROD1 positive cells were seen and expression was also observed in cells lining the maternal spiral arteries. The CD31 staining shows the location of endothelial cells (blue, arrows) lining the inner wall of the maternal spiral arteries (Fig. 3D ). These data show a progressive upregulation of NEUROD1 from zone IV to V.
Immunostaining for NEUROD2 was carried out in combination with HLA-G and Ki-67 or CD31 and is shown in Fig. 3E -H. These results show (Fig. 3E) proliferative Ki-67 positive cytotrophoblasts in phases I-III of the tissue, lining a clearly visible villus. Deeper into the tissue, HLA-G positive cells representative of the distal column were visible. In the interstitial zone IV (Fig. 3F) , HLA-G positive cells were observed. However, in this case no expression of NEUROD2 was observed. Further deeper in the tissue (Fig. 3G ) in zone V, the cells close to the indicated maternal spiral artery are strongly NEUROD2 positive. The CD31 staining shows the location of endothelial cells (blue, arrows) (Fig. 3H) . ATH2 protein expression could not be analyzed due to the absence of reactive antibodies. So far, achaete-scute and atonal-like bHLH genes have been described to be involved in neurogenesis (Jan and Jan, 1993; Guillemot, 1995; Lee et al., 1995; Chan and Jan, 1999; Kim et al., 2001; Marquardt et al., 2001 ), development of neuroendocrine epithelial cells (Ito et al., 2000) and pancreas beta cell development (Naya et al., 1997) . These data show that proneural gene expression is not limited to neuron tissues, but is also involved in differentiation regulating networks of other tissues as well. The function of proneural genes is apparently dependent on the context of the cell i.e. NEUROD1 has different functions during neurogenesis and pancreas differentiation. This is the first time that proneural bHLH genes of the NeuroD family have been shown to be expressed in the placenta. Both proneural genes NEUROD1 and NEUROD2 are expressed in subsets of invading cytotrophoblasts. Expression of these proneural genes in a clear spatial distri- Fig. 2 . RT-PCR expression profile of Achaete-scute, NeuroD, Neurogenin, Atonal and Beta bHLH families in brain, villous fibroblasts and first trimester placentabed, respectively. All genes analyzed were expressed in fetal brain (week 13). In the villous fibroblasts, only ASCL2 (HASH2/HASAP) expression was observed, in agreement with our earlier data (Westerman et al., 2001 ). In the first trimester placentabed, NEUROD1, NEUROD2 and ATH2 were reproducibly detected. GAPDH was used as a positive control for the RT-PCR and shows positive signals in all samples tested. Fig. 3 . NEUROD1 is expressed in interstitial and endovascular trophoblasts. Fluorescent triple immunostaining on cryostat sections of a 13-week placenta was carried out using confocal laser scan microscopy. Ki-67 positive (blue) proliferative cytotroptrophoblasts (arrows) are located in the proximal zone I-III (A). HLA-G positive (red) extravillous trophoblasts in the interstitial and endovascular zone IV and V show co-expression of NEUROD1 (green), visualized by a yellow color (arrows, B and C). Localization of NEUROD1 positive endovascular trophoblasts near spiral arteries is confirmed by CD31 staining (blue) of endothelial cells (arrows, D). NEUROD2 is expressed in endovascular trophoblasts. Ki-67 positive (blue) proliferative cytotroptrophoblasts (arrows) are lining an anchoring villous in zone I-III (E). HLA-G positive (red) extravillous trophoblasts (arrows) in the interstitial zone IV show no expression of NEUROD2 (F). However, HLA-G positive (red) endovascular trophoblasts (arrows) of zone V, located near the maternal spiral arteries show co-expression of NEUROD2 (green), visualized by a yellow color (G). Localization of NEUROD2 positive endovascular trophoblasts near spiral arteries is confirmed by CD31 staining (blue) of endothelial cells (arrows, panel H). bution pattern suggests the presence of a differentiation cascade during trophoblast invasion.
These data could initiate further insights into the genetic regulation of human placentation and might lead to a better understanding of pregnancy related disorders.
Materials and methods

Tissues
Tissue 10773 from a hysterectomy imposed by a cervixcarcinoma in an otherwise healthy woman with a normal pregnancy of week 13 gestational age, was obtained by the Department of Pathology, Radboud Hospital, Nijmegen, the Netherlands. The fetus was male as confirmed by PCR. Positive identification of fetal cells was performed by using Y-chromosome specific probes, specifity of HLA-G staining was confirmed by simulateous HLA-G immunostaining and FISH using Y-chromosome specific probes (van Wijk et al., 2002) . Tissues were stored frozen at 2708C.
RT-PCR
RT-PCR was performed as described before (Westerman et al., 2001) . Primer sequences are listed in Table 1 .
Immunocytochemistry
Frozen tissue sections of placentabed (20 mm) were fixed for 10 min with aceton at room temperature. Non-specific reactivity was blocked by incubating the sections in phosphate buffered saline (PBS) containing 0.1% blocking reagent (Roche) and 0.05% Triton X-100 (Sigma) for 30 min. Washing consisted of a 3 £ 3 min washing in PBS containing 0.05% Triton X-100. The sections were incubated overnight at 58C with the primary antibodies in the blocking buffer. Primary antibodies were: anti-HLA-G G233 mouse monoclonal , NH 2 LTFLFSEFGLLSDVPK) rabbit polyclonal (Kume et al., 1998; dilution 1:250) . Both NEUROD antibodies stained in the hippocampus pyramidal and granule cell layer as well as in the dorsal telencephalon of day 18 dpc rat brain. After washing, the sections were incubated with the secondary antibodies in blocking buffer for 30 min each in the dark. Secondary antibodies were: Alexa Fluor-647 goat anti-mouse IgG 1 (A-21240, Molecular Probes), Alexa Fluor-568 goat anti-mouse IgG 2a (A21134), Alexa Fluor-488 goat anti-rabbit IgG (H 1 L) (A11008), Alexa Fluor-488 donkey anti-goat IgG (H 1 L), (A11055). Blocking with 5% normal goat serum (Dako, X0501) for 30 min was performed when necessary. Between each secondary antibody incubation step, washing was performed. All Alexa antibodies were used in a 1:100 dilution, except in combination with NEUROD2, where a dilution of 1:50 was used. Finally the sections were washed and embedded in Prolong Antifade (Molecular Probes). Antibody binding was visualized on a confocal laser microscope (Leica).
